1 / 6CLSA on Maruti Suzuki: CLSA has maintained its 'Sell' call on Maruti Suzuki and said that the call is premised on expectations of the weakening of its model cycle.
2 / 6CLSA on Godrej Consumer: The brokerage has maintained an 'Outperform' rating on Godrej Consumer with a target price of Rs 715 per share. CLSA expects sales and earnings CAGR at 8 percent and 13 percent in FY20-23.
3 / 6CLSA on Oberoi Realty: The brokerage believes that the company is focussed on growth despite weak Q1FY21 and said that it is well-positioned due to its strong balance sheet.
4 / 6CLSA on Pharma: CLSA said that India's pharma market has turned positive and normalization of buying has helped chronic therapy growth remain robust. CLSA upgraded Torrent Pharma to a 'Buy' from 'Outperform' call with a TP of Rs 2,920 per share.
5 / 6CLSA on Oil & Gas: The brokerage says GAIL, GSPL, Petronet & Gujarat Gas may show faster volume rebounds while retail volumes of IGL and MGL may take longer to normalise.
6 / 6Credit Suisse on L&T Finance Holdings: The brokerage has maintained 'Underperform' call on the stock with a target of Rs 50 per share.
